Recombinant human interleukin 10 for induction of remission in Crohn's disease
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To determine the efficacy and tolerability of recombinant human interleukin 10 (IL‐10) for induction of remission in Crohn's disease.